The Horse

SEP 2018

The Horse:Your Guide To Equine Health Care provides monthly equine health care information to horse owners, breeders, veterinarians, barn/farm managers, trainer/riding instructors, and others involved in the hands-on care of the horse.

Issue link: https://thehorse.epubxp.com/i/1011863

Contents of this Issue

Navigation

Page 32 of 59

IMPORTANT SAFETY INFORMATION: PRASCEND is for use in horses only. Treatment with PRASCEND may cause loss of appetite. Most cases are mild. Weight loss, lack of energy, and behavioral changes also may be observed. If severe, a temporary dose reduction may be necessary. PRASCEND has not been evaluated in breeding, pregnant, or lactating horses and may interfere with reproductive hormones in these horses. PRASCEND Tablets should not be crushed due to the potential for increased human exposure. Refer to package insert for complete product information. Decreased athletic performance. Different attitude. Change in sweating. Delayed shedding compared to herdmates. Tendonitis. These are a few of the early signs associated with PPID. If you've recognized any of these signs in your horse, no matter the age, talk to your veterinarian to see if your horse is at risk for PPID. With timely diagnosis and Prascend ® (pergolide tablets), you can manage the signs of PPID so that your horse leads a long, happy, productive life. Visit PRASCEND.com to learn more about the clinical signs of PPID in horses, and talk to your veterinarian. Can you recognize the signs associated with PPID? ®PR ASCEND is a registered trademark of Boehringer Ingelheim GmbH, licensed to Boehringer Ingelheim Vetmedica, Inc. ©2018 Boehringer Ingelheim Vetmedica, Inc. All rights reserved. EQU-0626-PRAS0418

Articles in this issue

Links on this page

Archives of this issue

view archives of The Horse - SEP 2018